Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2018, Vol. 45 Issue (6): 813-816    DOI: 10.12891/ceog4113.2018
Original Research Previous articles | Next articles
Pelvic floor muscle thickness in women with polycystic ovary syndrome
M.H. Vieira de Melo1, M.T. Albuquerque Barbosa Cabral Micussi2, R. Dias de Medeiros3, R. Ney Cobucci4, T.M. de Oliveira Maranhão3, A.K. Gonçalves3, *()
1 Health Sciences Graduate Program of the Federal University of Rio Grande do Norte, Natal, Brazil
2 Department of Physical Therapy of the Federal University of Rio Grande do Norte, Nata, Brazil
3 Department of Gynecology and Obstetrics of the Federal University of Rio Grande do Norte, Natal, Brazil
4 Department of Gynecology and Obstetrics of the Potiguar University, Natal, Brazil
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Objective: To evaluate pelvic floor muscle (PFM) thickness in women with polycystic ovary syndrome (PCOS) group and compare it to those with normal menstrual cycle (control group). Materials and Methods: Transperineal ultrasound examination was used to evaluate the thickness of the bilateral pelvic floor muscles Results: The mean age was 25.1 ± 2.1 and 24.2 ± 1.9 years in PCOS and control groups, respectively (p > 0.05). Body mass index averaged 22.5 ± 0.9 in the control group and 27.8 ± 2.6 in the PCOS group (p = 0.03). There was no difference between the thickness of the pelvic floor muscles (PCOS group: right 1.12 ± 0.5, left 1.0 ± 0.6 and control group: right 0.89 ± 0.6 and left 0.94 ± 0.4. Conclusions: There was no differences in pelvic floor muscle thickness identified by ultrasound. However, the PCOS group exhibited a tendency to greater thickness. This may be due to the state of hyperandrogenism or abdominal overload.
Key words:  Hyperandrogenism      Pelvic floor      Polycystic ovary syndrome      Muscle     
Published:  10 December 2018     
*Corresponding Author(s):  A.K. GONÇALVES     E-mail:  anakatherine_ufrnet@yahoo.com.br

Cite this article: 

M.H. Vieira de Melo, M.T. Albuquerque Barbosa Cabral Micussi, R. Dias de Medeiros, R. Ney Cobucci, T.M. de Oliveira Maranhão, A.K. Gonçalves. Pelvic floor muscle thickness in women with polycystic ovary syndrome. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 813-816.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4113.2018     OR     https://ceog.imrpress.com/EN/Y2018/V45/I6/813

[1] J. Dun, X. Wang, J. Yang, J. Xu. Clinical practice guidelines on polycystic ovary syndrome: a systematic review and comparative meta-analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 465-471.
[2] P. Okrzymowska, M. Kurtys, N. Smolarek, M. Kurzaj, R. Slopien, K. Rozek-Piechura. Lung ventilation and the strength of the respiratory muscles of women in the third trimester of pregnancy in the aspect of physical activity[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 324-328.
[3] J.A. García-Mejido, C. Suarez-Serrano, E.M. Medrano-Sanchez, M.J. Bonomi Barby, A. Armijo Sánchez, J.A. Sainz. Pelvic floor rehabilitation in patients with levator ani muscle avulsion[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 341-347.
[4] Xiao-Tao Huang, Shao-Rong Liang, Lu Wang. Acupuncture combined with Chinese and western medicine in the treatment of polycystic ovary syndrome[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 396-400.
[5] A. M. Maysara, A. T. Nassar, H. K. Jubran. The effect of correction of serum level of vitamin D on hyperandrogenism in women with polycystic ovary syndrome and hypovitaminosis D[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 272-276.
[6] H.M.G. Youssef, E.S. Marei, L.A. Rashed. Long non-coding RNA steroid receptor activator in polycystic ovary syndrome: possible association with metabolic syndrome[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 757-762.
[7] I. Pimentel-Soares, A. C. Sartorato Beleza, M. da Silva Corrêa, M. Vieira Batistão, P. Driusso. Long-term effect of first childbirth on pelvic floor muscle function: cross-sectional study[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 630-634.
[8] Hui-lan Wang, Xia Xu, Zhi-qun Zheng. The expression of Nuclear Factor-κB in a rat model of polycystic ovary syndrome[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 276-279.
[9] H.W. Ma, X.R. Qi, L.L. Kong, Y. Chen, X. Zhao, L.Z. Xu. An unexpected neoplasm occurring after vaginoplasty using surgisis soft tissue graft in a patient with Mayer-Rokitansky-Küster-Hauser Syndrome: a novel side-reaction case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(4): 619-621.
No Suggested Reading articles found!